Kevin Patrick Moran - Jun 15, 2023 Form 4 Insider Report for Vanda Pharmaceuticals Inc. (VNDA)

Role: SVP, CFO & Treasurer
Signature: /s/ Kevin Patrick Moran
Stock symbol: VNDA
Transactions as of: Jun 15, 2023
Transactions value $: -$100,710
Form type: 4
Date filed: 6/20/2023, 04:34 PM
Previous filing: Mar 6, 2023
Next filing: Aug 1, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VNDA	Common Stock	Sale	-$101K	-16K	-11.52%	$6.29	123K	Jun 15, 2023	Direct	F1
holding	VNDA	Common Stock						635	Jun 15, 2023	By Wife

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.23 to $6.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.

Content

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.23 to $6.34, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.